AzTrials
AzTrials

AnxietySlowPACENCT06192225

Peri-operative Slow-paced Breathing to Reduce Anxiety in Breast Cancer Surgery Patients

A study testing pre-trained guided slow paced breathing (~6 breaths per minute) in people with Anxiety, run by The Netherlands Cancer Institute at 1 site in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this single-center trial is to examine the effects of a slow-breathing technique performed at induction of anesthesia in patients undergoing surgery for breast cancer on anxiety, scored by Spielberger's State-Trait Anxiety Inventory, state scale (STAI-S),13 compared to usual care. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Anxiety
What is being tested?
pre-trained guided slow paced breathing (~6 breaths per minute)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteNetherlands
Study dates
29 Nov 2023to 2 Nov 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Female
  • Undergoing surgery for breast cancer in the Antoni van Leeuwenhoekziekenhuis

Who cannot join

  • Age < 18 years
  • ASA ≥ 4
  • History of severe pulmonary illness: severe asthma or severe chronic obstructive pulmonary disease (COPD) GOLD III or IV
  • Known or suspected severe psychiatric disorder
  • Unable to give written or oral informed consent
  • Patient refusal
Show all 9Show fewer
  • Not able to understand Dutch
  • No internet access
  • Visual or hearing impairments interfering with reading and listening to the online material

Trial locations and contacts

1 site in 1 country.

Sabrine NT Hemmes, PhD contact

+20205124068

s.hemmes@nki.nl

Netherlands1 site, 1 recruiting
  • Antoni van Leeuwenhoek hospital

    Amsterdam, 1066 CX

    Sabrine Hemmes, MD, PhD, +205124068, s.hemmes@nki.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: Peri-operative Slow-paced Breathing - a Non-invasive Technique to Reduce Anxiety in Breast Cancer Surgery Patients

The purpose of this single-center trial is to examine the effects of a slow-breathing technique performed at induction of anesthesia in patients undergoing surgery for breast cancer on anxiety, scored by Spielberger's State-Trait Anxiety Inventory, state scale (STAI-S),13 compared to usual care.

Read the detailed description

Rationale: In the perioperative period anxiety for anesthesia and the surgical procedure is common. Breast cancer surgery patients have a higher level of anxiety compared to other patients undergoing (cancer) surgery. Relaxation techniques, like breath focus with deep belly breathing are easy to learn and can have a beneficial effect on postoperative anxiety, pain, and postoperative nausea and vomiting (PONV), but the quality of evidence is low. Slow paced breathing at a frequency of 6 breaths per minute can possibly increase vagal activation, decrease anxiety, reduce mean blood pressure, and postoperative pain.

The investigators aim to apply a pre-trained slow paced breathing technique at induction of anesthesia for surgery, to reduce perioperative anxiety and to explore effects on pre-operative blood pressure, per-operative need of hypnotics, postoperative pain and opioid use, PONV and patient satisfaction.

Objective: This study aims to examine the effects of guided slow paced breathing performed at induction of anesthesia in patients undergoing surgery for breast cancer on anxiety, scored by Spielberger's State-Trait Anxiety Inventory, State scale (STAI-S), compared to usual care.

Study design: Single center, two-group, prospective, randomized controlled trial Study population: patients scheduled for surgery for breast cancer in the Antoni van Leeuwenhoek Hospital.

Intervention: Performance of pre-trained guided slow paced breathing by the patient at induction of anesthesia for breast surgery.

Main study parameters: Anxiety scored by Spielberger's State Anxiety Inventory (STAI-S) Nature and extent of the burden and risks associated with participation, benefit and group relatedness: There are no risks related to the intervention. Participants randomized in the intervention group are trained in slow paced breathing after inclusion and asked to practice the technique daily until the day of surgery. All participants are asked to complete three questionnaires at baseline, and two short questionnaires on the day of surgery and at day 1.

Conditions
Anxiety
Being tested
pre-trained guided slow paced breathing (~6 breaths per minute)
Medical subject headings
Anxiety Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pre-trained guided slow paced breathing (~6 breaths per minute)Behavioural

    Slow PACE breathing

Study groups in NCT06192225
Study groupRoleWhat they receive
Slow PACE armExperimentalThe intervention consists of performance of pre-trained guided Slow PACE breathing by the patient at induction of anesthesia for breast cancer surgery.
Receives: Behavioral: pre-trained guided slow paced breathing (~6 breaths per minute)
Control armNo interventionCare as usual

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Peri operative anxiety

    The present study aims to examine the effects of pre-trained guided Slow PACE breathing performed at induction of anesthesia in patients undergoing surgery for breast cancer on anxiety, scored by Spielberger's State-Trait Anxiety Inventory, state scale (STAI-S), compared to usual care.

    The total score ranging from 20 to 80. Higher scores indicate higher levels of anxiety symptoms. A cut-off score of 40 is commonly used to define probable clinical levels of anxiety.

    Measured: 2 weeks

Secondary outcomes (8)
  1. mean blood pressure before induction

    MAP (mmHg)

    Measured: 10 minutes

  2. need of hypnotics during induction

    total dose of hypnotics (propofol in milligrams)

    Measured: 10 minutes

  3. post-operative pain

    visual analoge score (VAS) for pain, 0-10 points. A VAS score > 4 indicates the need of more pain medication

    Measured: post-operative on recovery (1-2hours)

  4. post-operative need of opioids

    Mean cumulative intravenous opioid dose administered during admission in the recovery room - converted to morphine equivalent dose (MEQ)

    Measured: post-operative on recovery (1-2hours)

  5. postoperative nausea and vomiting (PONV)

    Y/N

    Measured: post-operative on recovery (1-2hours)

  6. patient satisfaction

    scale of 0 (extremely unsatisfied) to 10 (extremely satisfied)

    Measured: 5 minutes on postoperative day 1

  7. Anxiety trait scored by Spielberger's State Anxiety Inventory (STAI-T)13 at baseline

    4-point scale ranging from 1 (not at all) to 4 (very much so), with the total score ranging from 20 to 80. Higher scores indicate higher levels of anxiety symptoms. A cut-off score of 40 is commonly used to define probable clinical levels of anxiety. The STAI-T will give an estimation of patients at high risk for anxiety.

    Measured: once at baseline, duration 10 minutes

  8. Hospital Anxiety and Depression Scale (HADS-A)

    A questionnaire for detecting states of anxiety and depression in a hospital setting. The HADS-A is the anxiety subscale that consists of seven items. Each item is rated on a 4-point scale (ranging from 0 = no not at all, to 3 = yes definitely), for a total score ranging from 0 to 21. A subscale score above 8 denotes anxiety.

    Measured: once at baseline, duration 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2024
  2. Study start29 Nov 2023
  3. Primary completion1 Nov 2025 (estimated)
  4. Study completion2 Nov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Single center, two-group, prospective, randomized controlled trial
Masking
None (open label)
Enrolment
150 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06192225
Sponsor's protocol ID
N23SLO
Acronym
SlowPACE
Status last verified
Oct 2023
First submitted
22 Jun 2023
Last updated
5 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: currently there are no other researchers

Publications

  • Spielberger, C.D. (2010). State-Trait Anxiety Inventory. In The Corsini Encyclopedia of Psychology (eds I.B. Weiner and W.E. Craighead).

  • Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.1600-0447.1983.tb09716.x.

    PubMed 6880820

Questions about this trial

What is this clinical trial studying?

A study testing pre-trained guided slow paced breathing (~6 breaths per minute) in people with Anxiety, run by The Netherlands Cancer Institute at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Sabrine NT Hemmes, PhD (+20205124068, s.hemmes@nki.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Peri operative anxiety (time frame: 2 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06192225, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in